Xiao Hui Ji
Directeur/Membre du Conseil chez LEGEND BIOTECH CORPORATION
Fortune : 408 066 $ au 30/06/2024
Profil
Xiao Hui Ji is the founder of Elpiscience Biopharma Ltd.
(founded in 2017) and Elpiscience Biopharmaceuticals, Inc. (founded in 2017).
He held the title of Chairman & Chief Executive Officer at both companies.
Dr. Ji is also the founder of PharmaLegacy Laboratories (Shanghai) Co., Ltd.
.
Dr. Ji's current job is as an Independent Director at Legend Biotech Corp.
(since 2020).
Dr. Ji's former jobs include being a Director at The BayHelix Group (from 2008 to 2013), Vice President-Business Development at Roche Holding AG (from 2013 to 2016), and a Partner at LAV Management Co., Ltd.
(from 2017 to 2020).
Dr. Ji's education includes an MBA from The University of Chicago, a doctorate from The University of Sheffield, and a doctorate from China Medical University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LEGEND BIOTECH CORP.
0,01% | 31/12/2023 | 18 427 ( 0,01% ) | 408 066 $ | 30/06/2024 |
Postes actifs de Xiao Hui Ji
| Sociétés | Poste | Début |
|---|---|---|
| LEGEND BIOTECH CORPORATION | Directeur/Membre du Conseil | 01/05/2020 |
Elpiscience Biopharma Ltd.
 Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Directeur Général | 01/06/2017 |
Elpiscience Biopharmaceuticals, Inc.
 Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Directeur Général | 01/06/2017 |
Anciens postes connus de Xiao Hui Ji
| Sociétés | Poste | Fin |
|---|---|---|
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Corporate Officer/Principal | 01/05/2020 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01/12/2016 |
| The BayHelix Group | Directeur/Membre du Conseil | 01/01/2013 |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
 PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Directeur Général | 01/01/2012 |
Formation de Xiao Hui Ji
| China Medical University | Doctorate Degree |
| The University of Sheffield | Doctorate Degree |
| The University of Chicago | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| LEGEND BIOTECH CORPORATION | Health Technology |
| ROCHE HOLDING AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Elpiscience Biopharma Ltd.
Elpiscience Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Elpiscience Biopharma Ltd. engages in the development of cutting-edge immunotherapies to fight cancer. Its business scope includes technology research and development, transfer of own technology achievements and provision of related technical advice and technical services of biomedicine and biotechnology; import and export, and wholesale of mechanical equipment, electronic products, instrumentation, and plastic products. The company was founded on September 30, 2017 and is headquartered in Shanghai, China. | Health Technology |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
| The BayHelix Group | |
PharmaLegacy Laboratories (Shanghai) Co., Ltd.
PharmaLegacy Laboratories (Shanghai) Co., Ltd. Miscellaneous Commercial ServicesCommercial Services PharmaLegacy Laboratories (Shanghai) Co., Ltd. engages in the provision of pharmacodynamics, pharmacokinetics, non-GLP toxicology, in vitro immunology, and three types of medical device evaluation services in line with international standards. It provides drug research & development preclinical research services such as pharmacodynamic research evaluation and pharmacokinetic research evaluation; device research & development preclinical research services such as preclinical effectiveness and safety evaluation of innovative medical devices; and experimental mice. The company was founded on March 7, 2008 and is headquartered in Shanghai, China. | Commercial Services |
Elpiscience Biopharmaceuticals, Inc.
Elpiscience Biopharmaceuticals, Inc. BiotechnologyHealth Technology Elpiscience Biopharmaceuticals, Inc. is an investment holding company, which engages in the research and development of immuno-oncology therapies. It focuses on the development of clinical-stage drug candidates namely, ES102, ES014, ES104, and ES009. The company was founded by Xiao Hui Ji and Hong Tao Lu in June 2017 and is headquartered in Shanghai, China. | Health Technology |
